Inventor
KOHARA MICHINORI
JP21 patents
⚠️ This page may combine multiple inventors who share the name “KOHARA MICHINORI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TOKYO METROPOLITAN INST MEDICAL SCIENCE
6 patentsUS12458658B2Nov 4, 2025
Composition for inhibiting replication of hepatitis B virus
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations55
US12280099B2Apr 22, 2025
Dengue virus vaccine
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations55
US11051496B2Jul 6, 2021
Urokinase-type plasminogen activator transgenic mouse
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations54
US11517741B2Dec 6, 2022
Electrodes for electroporation
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations50
US9955675B2May 1, 2018
Urokinase-type plasminogen activator transgenic mouse
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations43
US10160979B2Dec 25, 2018
Pharmaceutical composition for treatment and/or prevention of hepatitis C
TOKYO METROPOLITAN INST MEDICAL SCIENCE0 citations32
KOHARA MICHINORI
3 patentsUS9000136B2Apr 7, 2015
Recombinant vaccinia virus having hepatitis C virus gene
KOHARA MICHINORI0 citations46
US8957199B2Feb 17, 2015
Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis C virus
KOHARA MICHINORI0 citations46
US8609403B2Dec 17, 2013
Polynucleotide derived from novel hepatitis C virus strain and use thereof
KOHARA MICHINORI0 citations46